文献速递腹部技术与安全MR

肝硬化肝脏MRI新发动脉期强化结节:进展为肝细胞癌的风险及对LI-RADS分类的意义

New Arterial Phase Enhancing Nodules on MRI of Cirrhotic Liver: Risk of Progression to Hepatocellular Carcinoma and Implications for LI-RADS Classification.
PubMed 文献 · AJR Am J Roentgenol · 2020-05-20

本研究评估了肝硬化患者MRI上新发动脉期强化结节进展为肝细胞癌的结果及影响因素,并比较LI-RADSv2018与v2017对这些结节的分类诊断效能。129个结节中71个(55%)进展为HCC;LI-RADS评分、轻度至中度T2高信号、血清甲胎蛋白、乙肝或丙肝感染病因及其他HCC存在为进展预测因素。

要点

  • 肝硬化MRI新发动脉期强化结节进展为HCC的比例达55%(71/129)。
  • LI-RADSv2018分类下3类和4类结节进展率分别为44.4%和69.9%。
  • 血清甲胎蛋白水平、其他HCC存在是进展为HCC的强预测因素。

关键影像表现/征象

  • 结节为动脉期强化、圆形、实性、占位性病变。
  • 轻度至中度T2高信号是进展为HCC的独立预测因素(单因素分析)。

诊断标准与关键数值

  • LI-RADSv2017分类3类结节进展率为38.1%,4类为57.6%。
  • LI-RADSv2018分类3类结节进展率为44.4%,4类为69.9%。
  • LI-RADSv2017评分和LI-RADSv2018评分均为进展为HCC的独立预测因素(单因素分析)。

临床应用与阅片要点

  • 对肝硬化MRI新发动脉期强化结节应依据LI-RADS分类评估进展风险。
  • 血清甲胎蛋白水平、乙肝或丙肝感染病因及其他HCC存在可用于风险分层。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The purposes of this study were to evaluate the outcome of new arterial phase enhancing nodules at MRI of cirrhotic livers, including clinical and imaging factors that affect progression to hepatocellular carcinoma (HCC), and to assess the diagnostic performance of Liver Imaging Reporting and Data System version 2018 (LI-RADSv2018) versus version 2017 (LI-RADSv2017) in categorizing these nodules. MATERIALS AND METHODS. A database search identified 129 new arterial phase enhancing, round, solid, space-occupying nodules in 79 patients with cirrhosis who underwent surveillance MRI. Three readers assessed the nodules for LI-RADS findings and made assessments based on the 2017 and 2018 criteria. Clinical information and laboratory values were collected. Outcome data were assessed on the basis of follow-up imaging and pathology results. Interreader agreement was assessed. Logistic regression and ROC curve analyses were used to assess the utility of the features for prediction of progression to HCC. RESULTS. Of the 129 nodules, 71 (55%) progressed to HCC. LI-RADSv2017 score, LIRADSv2018 score, and mild-to-moderate T2 hyperintensity were significant independent predictors of progression to HCC in univariate analyses. Serum α-fetoprotein level, hepatitis B or C virus infection as the cause of liver disease, and presence of other HCCs were significant predictors of progression to HCC in multivariate analyses. The rates of progression of LI-RADS category 3 and 4 observations were 38.1% and 57.6%, respectively, for LI-RADSv2017 and 44.4% and 69.9%, respectively, for LI-RADSv2018. CONCLUSION. New arterial phase enhancing nodules in patients with cirrhosis frequently progress to HCC. Factors such as serum α-fetoprotein level and presence of other HCCs are strong predictors of progression to HCC.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Smereka P, Doshi AM, Lavelle LP, et al. New Arterial Phase Enhancing Nodules on MRI of Cirrhotic Liver: Risk of Progression to Hepatocellular Carcinoma and Implications for LI-RADS Classification. AJR Am J Roentgenol. 2020. PMID: 32432909. doi:10.2214/AJR.19.22033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。